Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Centre Oscar Lambret
Centre Oscar Lambret
Eisai Inc.
WestVac Biopharma Co., Ltd.
The Methodist Hospital Research Institute
Hospital Universitari de Bellvitge
NeoImmuneTech
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Daewoong Pharmaceutical Co. LTD.
AbbVie
Psyence Australia Pty Ltd
Eli Lilly and Company
ViroMissile, Inc.
WellSpan Health
Eisai Inc.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Cancer Research UK
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
AbbVie
Pfizer
Hospices Civils de Lyon
Duke University
A2 Biotherapeutics Inc.
Tata Memorial Hospital
Immatics US, Inc.
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
A2 Biotherapeutics Inc.
AstraZeneca
Hackensack Meridian Health
Daiichi Sankyo
Tata Memorial Hospital
Unity Health Toronto
Imperial College London
Pheon Therapeutics
DualityBio Inc.
AstraZeneca
EXoPERT
Colorado State University